Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Torralba

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|July 26, 2021
Women, men, and HIV infection: One virus, two epidemicsMiguel Torralba
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|October 8, 2021
Women, men, and HIV infection: One virus, two epidemicsMiguel Torralba
Journal of HIV Therapy|May 9, 2003
NNRTI hepatotoxicity: efavirenz versus nevirapineFederico Pulido, Miguel Torralba
The Annals of Pharmacotherapy|July 23, 2021
Effectiveness, Durability, and Safety of Dolutegravir and Lamivudine Versus Dolutegravir, Lamivudine, and Abacavir in a Real-Life Cohort of HIV-Infected AdultsInés Mendoza, Alicia Lázaro, Miguel Torralba
Journal of Interpersonal Violence|January 4, 2018
Microfinance and Violence Against Women in Rural GuatemalaIsabel Cepeda, Maricruz Lacalle-Calderon, Miguel Torralba
Journal of Interpersonal Violence|August 18, 2021
Measuring Violence Against Women: A Global IndexIsabel Cepeda, Maricruz Lacalle-Calderon, Miguel Torralba
Medicina Clinica|July 14, 2018
Late diagnosis of HIV infection: Missed opportunitiesJavier Martínez-Sanz, Judith Rodríguez Albarrán, Miguel Torralba
Endocrinologia, Diabetes Y Nutricion|January 24, 2018
Clinical course of a cohort with type 2 diabetes mellitus after endocrine assessment. A 26-week studySandra Herranz-Antolín, Visitación Álvarez-de Frutos, Miguel Torralba
Contact Dermatitis|July 15, 2021
Response to Letter to the EditorMaría A Pastor-Nieto, María E Gatica-Ortega, Miguel Torralba
HIV Medicine|March 26, 2026
Use of long-acting cabotegravir and rilpivirine in people living with HIV: A prospective observational cohort studyAna Codonal, Alicia Lázaro, Elena Martínez, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|July 26, 2021
Women, men, and HIV infection: One virus, two epidemicsMiguel Torralba
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|October 8, 2021
Women, men, and HIV infection: One virus, two epidemicsMiguel Torralba
Journal of HIV Therapy|May 9, 2003
NNRTI hepatotoxicity: efavirenz versus nevirapineFederico Pulido, Miguel Torralba
The Annals of Pharmacotherapy|July 23, 2021
Effectiveness, Durability, and Safety of Dolutegravir and Lamivudine Versus Dolutegravir, Lamivudine, and Abacavir in a Real-Life Cohort of HIV-Infected AdultsInés Mendoza, Alicia Lázaro, Miguel Torralba
Journal of Interpersonal Violence|January 4, 2018
Microfinance and Violence Against Women in Rural GuatemalaIsabel Cepeda, Maricruz Lacalle-Calderon, Miguel Torralba
Journal of Interpersonal Violence|August 18, 2021
Measuring Violence Against Women: A Global IndexIsabel Cepeda, Maricruz Lacalle-Calderon, Miguel Torralba
Medicina Clinica|July 14, 2018
Late diagnosis of HIV infection: Missed opportunitiesJavier Martínez-Sanz, Judith Rodríguez Albarrán, Miguel Torralba
Endocrinologia, Diabetes Y Nutricion|January 24, 2018
Clinical course of a cohort with type 2 diabetes mellitus after endocrine assessment. A 26-week studySandra Herranz-Antolín, Visitación Álvarez-de Frutos, Miguel Torralba
Contact Dermatitis|July 15, 2021
Response to Letter to the EditorMaría A Pastor-Nieto, María E Gatica-Ortega, Miguel Torralba
HIV Medicine|March 26, 2026
Use of long-acting cabotegravir and rilpivirine in people living with HIV: A prospective observational cohort studyAna Codonal, Alicia Lázaro, Elena Martínez, et al.
Pageof 9